MEDICARE PRESCRIPTION

Aetna, with eye on regulators, sells Medicare drug business to WellCare

The $69 billion deal is being reviewed by the U.S. Department of Justice and if approved it would be the second largest healthcare deal this year - one that the companies say will help cut soaring costs in the sector.